Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The changing therapy of benign prostatic hyperplasia

J E Altwein1

  • 1Department of Urology, Krankenhaus der Barmherzigen Brüder, Munich, Germany.

Scandinavian Journal of Urology and Nephrology. Supplementum
|January 1, 1995
PubMed
Summary

Benign prostatic hyperplasia (BPH) diagnosis uses various criteria, impacting treatment choices. Medical therapies like alpha blockers are rising as surgery declines for BPH symptom management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unusually large numbers needed to treat for radical prostatectomy in prostate cancer patients with PSA velocity ≤2 ng/ml/year.

Urologia internationalis·2012
Same author

[LHRH analogues for the treatment of prostate cancer: an evidence level-based analysis].

Aktuelle Urologie·2009
Same author

[Primary prevention of bladder cancer. What's new?].

Der Urologe. Ausg. A·2007
Same author

[Local recurrence of prostate cancer: hormone therapy].

Der Urologe. Ausg. A·2006
Same author

Biphosphonates in advanced prostate and renal cell cancer--current status and potential applications.

Urologia internationalis·2006
Same author

[Fortuitous finding microhematuria].

MMW Fortschritte der Medizin·2005

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Benign prostatic hyperplasia (BPH) diagnosis and treatment are under continuous review.
  • Diagnosis can utilize microscopic, clinical, or urodynamic criteria, influencing management strategies.
  • Evolving market therapies and cost-effectiveness analyses drive treatment updates.

Purpose of the Study:

  • To review the spectrum of BPH treatment modalities.
  • To discuss factors influencing individual treatment selection for BPH.

Main Methods:

  • Literature review of current BPH diagnostic and therapeutic approaches.
  • Analysis of trends in surgical versus medical management.
  • Evaluation of pharmacological options for BPH symptoms.

Main Results:

  • Surgical interventions for BPH are decreasing.
  • Medical therapies, including alpha adrenoceptor blockers and 5-alpha reductase inhibitors, are increasingly established for mild to moderate BPH.
  • Pharmacological treatments are gaining prominence in BPH management.

Conclusions:

  • Treatment choice for BPH depends on diagnostic criteria and patient factors.
  • Medical management is becoming a more significant approach to treating BPH symptoms.
  • Urologists face a dynamic landscape of BPH treatment options.

Related Experiment Videos